NettetINSPIRATION Investigators, et al. "Effect of Intermediate-Dose Vs Standard-Dose Prophylactic Anticoagulation On Thrombotic Events, Extracorporeal Membrane … Nettet10. des. 2024 · The recent retrospective MPN-COVID trial, promoted by the European LeukemiaNet, found a cumulative incidence of 8.6% thrombosis in hospitalized patients …
Antithrombotic Therapy COVID-19 Treatment Guidelines
Nettet8. jul. 2024 · A recent report from the prospective INSPIRATION trial suggested no benefit of intermediate dose prophylactic anticoagulation over standard dose prophylactic … Nettet4. aug. 2024 · Among 75 registered clinical trials of different antithrombotic strategies with different agents in patients with Covid-19, a majority have involved the use of heparin … rohrbaugh pallet
The INSPIRATION Trial: Intermediate Dose Anticoagulation in …
Nettet18. okt. 2024 · Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients … Nettet21 Sadeghipour P, Talasaz AH, Rashidi F. et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane … Nettet27. apr. 2024 · ClinicalTrials.gov Identifier: NCT04486508. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal … outback arms